A detailed analysis of the Biochemical Sensor Market is entailed in this research report. The driving forces responsible for propelling the growth graph of this vertical in addition to the regional and competitive trends are mentioned in the study. A comprehensive document comprising details about vital parameters such as the industry ecosystem analysis, market segmentation, and the vendor matrix, the Market report also contains information on the pivotal industry insights for core players to look out for.

The Biochemical Sensor Market research report presents significant information on the methodology deployed to conceptualize the study in question, by means of various primary and secondary sources. The scope of the report and the elements contained in the same with respect to the growth spectrum of the Biochemical Sensor Market has been discussed in the study. Also mentioned in the document are details pertaining to the financial data of the companies profiled in the report, in addition to the currently prevalent price trends of the Biochemical Sensor Market.

Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/2709

Top Key Player are:

Type analysis:

Type segmentation: The report claims that the Type landscape of the Biochemical Sensor Market is subdivided into

Important pointers encompassed pertaining to the Type spectrum:

Application analysis:

Application segmentation: The report states the Application landscape of the Biochemical Sensor Market to be split into

Important pointers encompassed pertaining to the Application spectrum:

Request for Customization of this report @ https://www.gminsights.com/roc/2709

Other important pointers encompassed in the report:

An inherent collection of pivotal deliverables, the Biochemical Sensor Market study strives to educate stakeholders and prominent investors about the plausible scenario that this industry may be defined by in the ensuing years. Comprising significant details subject to the industry impact forces, Biochemical Sensor Market market report also presents a SWOT analysis, Porters analysis, and a gist on the industry pitfalls and challenges.

About Global Market InsightsGlobal Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:Arun HegdeCorporate Sales, USAGlobal Market Insights, Inc.Phone: 1-302-846-7766Toll Free: 1-888-689-0688Email: [emailprotected]

Read more:
Biochemical Sensor Market: Leading Segments and their Growth Drivers 2020-2026 - Fractovia News

The research led by Jeremy Wood, Zach Porterfield and Jamie Sturgill in the Department of Internal Medicine; Beth Garvy in Microbiology, Immunology & Molecular Genetics; and Wally Whiteheart in Molecular & Cellular Biochemistry, suggests localized inflammation in the lungs caused by COVID-19 may be responsible for the increased presence of blood clots in patients.

The study also provides evidence suggesting the risk of thrombosis could persist after the infection clears.

The study examined the blood of 30 COVID-19 patients including 15 who were inpatients in the intensive care unit, and 15 who received care as outpatients at UKs Infectious Diseases Clinic, along with eight disease-free volunteers who acted as a control group.

Compared to baseline, the COVID-19 patients had elevated levels of tissue factor, a protein found in blood that initiates the clotting process. Patients also had reduced levels of protein S, an anticoagulant that helps prevent blood clotting.

The researchers concluded that lung inflammation caused by COVID-19 is what leads to a decrease in protein S. Thisinflammation also causes immune and possible endothelial cell activation, which leads to increased tissue factor protein.

What weve learned is that the clotting is not caused by anything systemic. Localized inflammation in the lungs is whats driving this whole process, Wood said. With an increase in tissue factor and a deficiency in protein S, COVID-19 patients get more blood clotting without the ability to shut it down or control it.

The study additionally showed that protein S levels remained low in some patients even after they tested negative for COVID-19, which suggests that blood clotting issues may persist after infection and long-term monitoring of thrombotic risk may be necessary.

Wood says this preliminary data could be a cause for concern. Certain viruses like HIV are linked to a long-term deficiency in protein S, which causes an ongoing risk of thrombosis in patients. It is not yet known if COVID-19 could cause a similar persisting protein S deficiency.

Tissue factor and protein S are good markers to monitor for long-term thrombosis risk and the data suggest that we need to be monitoring these patients because were not seeing these parameters corrected immediately, Wood said.

The research team recently received a grant from UKsCenter for Clinical and Translational Science(CCTS) to begin a longitudinal study to look at these levels in patients over the next year.

This will help answer the question: will this risk remain like it is in the HIV patients or will it go away?

The study was funded in part by anAlliance Grantthrough the College of Medicine as well as UKsCOVID-19 Unified Research Experts (CURE) Alliancethroughthe Vice President for Research and the College of Medicine and the CCTS. It was a product of collaboration between a number of different groups at UK that have been studying COVID-19.

Additional collaborators includeMartha Sim, Meenakshi Banerjee and Hammodah Alfar in the Department of Molecular and Cellular Biochemistry; Melissa Hollifield and Jerry Woodward with Microbiology, Immunology and Molecular Genetics; Xian Li with the Saha Cardiovascular Research Center; Alice Thornton with the Division of Infectious Disease; and Gail Sievert, Marietta Barton-Baxter and Kenneth Campbell with CCTS.

Read more here:
UK research getting to bottom of COVID clots - ABC 36 News - WTVQ

Global Blood Cell Analyzer Market to Reach $2. 1 Billion by 2027. Amid the COVID-19 crisis, the global market for Blood Cell Analyzer estimated at US$1. 5 Billion in the year 2020, is projected to reach a revised size of US$2.

New York, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Blood Cell Analyzer Industry" - https://www.reportlinker.com/p05960820/?utm_source=GNW 1 Billion by 2027, growing at aCAGR of 4.8% over the period 2020-2027. Semi-automated Biochemistry Analyzers, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$539.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fully Automated Biochemistry Analyzers segment is readjusted to a revised 4.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $439.7 Million, While China is Forecast to Grow at 4.5% CAGR

The Blood Cell Analyzer market in the U.S. is estimated at US$439.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$366.3 Million by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 3.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.We bring years of research experience to this 8th edition of our report. The 277-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

Read the full report: https://www.reportlinker.com/p05960820/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW Global Competitor Market Shares Blood Cell Analyzer Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Blood Cell Analyzer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 2: World Historic Review for Blood Cell Analyzer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 3: World 15-Year Perspective for Blood Cell Analyzer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Semi-automated Biochemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 5: World Historic Review for Semi-automated Biochemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 6: World 15-Year Perspective for Semi-automated Biochemistry Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Fully Automated Biochemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 8: World Historic Review for Fully Automated Biochemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 9: World 15-Year Perspective for Fully Automated Biochemistry Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Bench-top by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 11: World Historic Review for Bench-top by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 12: World 15-Year Perspective for Bench-top by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Floor-standing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 14: World Historic Review for Floor-standing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 15: World 15-Year Perspective for Floor-standing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 17: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 18: World 15-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Drug development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 20: World Historic Review for Drug development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 21: World 15-Year Perspective for Drug development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 27: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 29: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 30: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 32: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 33: World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 35: World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 36: World 15-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 37: World Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 38: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 39: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 40: World Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 41: World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 42: World 15-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES Market Facts & Figures US Blood Cell Analyzer Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 43: USA Current & Future Analysis for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 44: USA Historic Review for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 45: USA 15-Year Perspective for Blood Cell Analyzer by Product Type - Percentage Breakdown of Value Sales for Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers for the Years 2012, 2020 & 2027

Table 46: USA Current & Future Analysis for Blood Cell Analyzer by Modality - Bench-top and Floor-standing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 47: USA Historic Review for Blood Cell Analyzer by Modality - Bench-top and Floor-standing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 48: USA 15-Year Perspective for Blood Cell Analyzer by Modality - Percentage Breakdown of Value Sales for Bench-top and Floor-standing for the Years 2012, 2020 & 2027

Table 49: USA Current & Future Analysis for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 50: USA Historic Review for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 51: USA 15-Year Perspective for Blood Cell Analyzer by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug development and Other Applications for the Years 2012, 2020 & 2027

Table 52: USA Current & Future Analysis for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 53: USA Historic Review for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 54: USA 15-Year Perspective for Blood Cell Analyzer by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2020 & 2027

CANADA Table 55: Canada Current & Future Analysis for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 56: Canada Historic Review for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 57: Canada 15-Year Perspective for Blood Cell Analyzer by Product Type - Percentage Breakdown of Value Sales for Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers for the Years 2012, 2020 & 2027

Table 58: Canada Current & Future Analysis for Blood Cell Analyzer by Modality - Bench-top and Floor-standing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 59: Canada Historic Review for Blood Cell Analyzer by Modality - Bench-top and Floor-standing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 60: Canada 15-Year Perspective for Blood Cell Analyzer by Modality - Percentage Breakdown of Value Sales for Bench-top and Floor-standing for the Years 2012, 2020 & 2027

Table 61: Canada Current & Future Analysis for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 62: Canada Historic Review for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 63: Canada 15-Year Perspective for Blood Cell Analyzer by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug development and Other Applications for the Years 2012, 2020 & 2027

Table 64: Canada Current & Future Analysis for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 65: Canada Historic Review for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 66: Canada 15-Year Perspective for Blood Cell Analyzer by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2020 & 2027

JAPAN Table 67: Japan Current & Future Analysis for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 68: Japan Historic Review for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 69: Japan 15-Year Perspective for Blood Cell Analyzer by Product Type - Percentage Breakdown of Value Sales for Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers for the Years 2012, 2020 & 2027

Table 70: Japan Current & Future Analysis for Blood Cell Analyzer by Modality - Bench-top and Floor-standing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 71: Japan Historic Review for Blood Cell Analyzer by Modality - Bench-top and Floor-standing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 72: Japan 15-Year Perspective for Blood Cell Analyzer by Modality - Percentage Breakdown of Value Sales for Bench-top and Floor-standing for the Years 2012, 2020 & 2027

Table 73: Japan Current & Future Analysis for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 74: Japan Historic Review for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 75: Japan 15-Year Perspective for Blood Cell Analyzer by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug development and Other Applications for the Years 2012, 2020 & 2027

Table 76: Japan Current & Future Analysis for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 77: Japan Historic Review for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 78: Japan 15-Year Perspective for Blood Cell Analyzer by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2020 & 2027

CHINA Table 79: China Current & Future Analysis for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 80: China Historic Review for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 81: China 15-Year Perspective for Blood Cell Analyzer by Product Type - Percentage Breakdown of Value Sales for Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers for the Years 2012, 2020 & 2027

Table 82: China Current & Future Analysis for Blood Cell Analyzer by Modality - Bench-top and Floor-standing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 83: China Historic Review for Blood Cell Analyzer by Modality - Bench-top and Floor-standing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 84: China 15-Year Perspective for Blood Cell Analyzer by Modality - Percentage Breakdown of Value Sales for Bench-top and Floor-standing for the Years 2012, 2020 & 2027

Table 85: China Current & Future Analysis for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 86: China Historic Review for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 87: China 15-Year Perspective for Blood Cell Analyzer by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug development and Other Applications for the Years 2012, 2020 & 2027

Read more from the original source:
Global Blood Cell Analyzer Industry - Yahoo Finance

LOS ANGELES, United States: QY Research has recently published a research report titled, Global Biochemical Reagent Market Research Report 2020. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Biochemical Reagent market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Biochemical Reagent market.

The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Biochemical Reagent market.

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Biochemical Reagent market.

Key questions answered in the report:

TOC

Table of Contents 1 Biochemical Reagent Market Overview1.1 Product Overview and Scope of Biochemical Reagent1.2 Biochemical Reagent Segment by Type1.2.1 Global Biochemical Reagent Sales Growth Rate Comparison by Type (2021-2026)1.2.2 Chromatography1.2.3 Mass Spectrometry1.2.4 Electrophoresis1.3 Biochemical Reagent Segment by Application1.3.1 Biochemical Reagent Sales Comparison by Application: 2020 VS 20261.3.2 Protein Synthesis and Purification1.3.3 Gene Expression1.3.4 DNA and RNA Analysis1.3.5 Drug Testing1.4 Global Biochemical Reagent Market Size Estimates and Forecasts1.4.1 Global Biochemical Reagent Revenue 2015-20261.4.2 Global Biochemical Reagent Sales 2015-20261.4.3 Biochemical Reagent Market Size by Region: 2020 Versus 2026 2 Global Biochemical Reagent Market Competition by Manufacturers2.1 Global Biochemical Reagent Sales Market Share by Manufacturers (2015-2020)2.2 Global Biochemical Reagent Revenue Share by Manufacturers (2015-2020)2.3 Global Biochemical Reagent Average Price by Manufacturers (2015-2020)2.4 Manufacturers Biochemical Reagent Manufacturing Sites, Area Served, Product Type2.5 Biochemical Reagent Market Competitive Situation and Trends2.5.1 Biochemical Reagent Market Concentration Rate2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)2.6 Manufacturers Mergers & Acquisitions, Expansion Plans2.7 Primary Interviews with Key Biochemical Reagent Players (Opinion Leaders) 3 Biochemical Reagent Retrospective Market Scenario by Region3.1 Global Biochemical Reagent Retrospective Market Scenario in Sales by Region: 2015-20203.2 Global Biochemical Reagent Retrospective Market Scenario in Revenue by Region: 2015-20203.3 North America Biochemical Reagent Market Facts & Figures by Country3.3.1 North America Biochemical Reagent Sales by Country3.3.2 North America Biochemical Reagent Sales by Country3.3.3 U.S.3.3.4 Canada3.4 Europe Biochemical Reagent Market Facts & Figures by Country3.4.1 Europe Biochemical Reagent Sales by Country3.4.2 Europe Biochemical Reagent Sales by Country3.4.3 Germany3.4.4 France3.4.5 U.K.3.4.6 Italy3.4.7 Russia3.5 Asia Pacific Biochemical Reagent Market Facts & Figures by Region3.5.1 Asia Pacific Biochemical Reagent Sales by Region3.5.2 Asia Pacific Biochemical Reagent Sales by Region3.5.3 China3.5.4 Japan3.5.5 South Korea3.5.6 India3.5.7 Australia3.5.8 Taiwan3.5.9 Indonesia3.5.10 Thailand3.5.11 Malaysia3.5.12 Philippines3.5.13 Vietnam3.6 Latin America Biochemical Reagent Market Facts & Figures by Country3.6.1 Latin America Biochemical Reagent Sales by Country3.6.2 Latin America Biochemical Reagent Sales by Country3.6.3 Mexico3.6.3 Brazil3.6.3 Argentina3.7 Middle East and Africa Biochemical Reagent Market Facts & Figures by Country3.7.1 Middle East and Africa Biochemical Reagent Sales by Country3.7.2 Middle East and Africa Biochemical Reagent Sales by Country3.7.3 Turkey3.7.4 Saudi Arabia3.7.5 U.A.E 4 Global Biochemical Reagent Historic Market Analysis by Type4.1 Global Biochemical Reagent Sales Market Share by Type (2015-2020)4.2 Global Biochemical Reagent Revenue Market Share by Type (2015-2020)4.3 Global Biochemical Reagent Price Market Share by Type (2015-2020)4.4 Global Biochemical Reagent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Biochemical Reagent Historic Market Analysis by Application5.1 Global Biochemical Reagent Sales Market Share by Application (2015-2020)5.2 Global Biochemical Reagent Revenue Market Share by Application (2015-2020)5.3 Global Biochemical Reagent Price by Application (2015-2020) 6 Company Profiles and Key Figures in Biochemical Reagent Business6.1 Thermo Fisher Scientific6.1.1 Corporation Information6.1.2 Thermo Fisher Scientific Description, Business Overview and Total Revenue6.1.3 Thermo Fisher Scientific Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.1.4 Thermo Fisher Scientific Products Offered6.1.5 Thermo Fisher Scientific Recent Development6.2 Beckman Coulter6.2.1 Beckman Coulter Biochemical Reagent Production Sites and Area Served6.2.2 Beckman Coulter Description, Business Overview and Total Revenue6.2.3 Beckman Coulter Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.2.4 Beckman Coulter Products Offered6.2.5 Beckman Coulter Recent Development6.3 Abbott6.3.1 Abbott Biochemical Reagent Production Sites and Area Served6.3.2 Abbott Description, Business Overview and Total Revenue6.3.3 Abbott Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.3.4 Abbott Products Offered6.3.5 Abbott Recent Development6.4 Merck & Co., Inc.6.4.1 Merck & Co., Inc. Biochemical Reagent Production Sites and Area Served6.4.2 Merck & Co., Inc. Description, Business Overview and Total Revenue6.4.3 Merck & Co., Inc. Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.4.4 Merck & Co., Inc. Products Offered6.4.5 Merck & Co., Inc. Recent Development6.5 Life Technologies6.5.1 Life Technologies Biochemical Reagent Production Sites and Area Served6.5.2 Life Technologies Description, Business Overview and Total Revenue6.5.3 Life Technologies Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.5.4 Life Technologies Products Offered6.5.5 Life Technologies Recent Development6.6 Bio-Rad6.6.1 Bio-Rad Biochemical Reagent Production Sites and Area Served6.6.2 Bio-Rad Description, Business Overview and Total Revenue6.6.3 Bio-Rad Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.6.4 Bio-Rad Products Offered6.6.5 Bio-Rad Recent Development6.7 Water Corporation6.6.1 Water Corporation Biochemical Reagent Production Sites and Area Served6.6.2 Water Corporation Description, Business Overview and Total Revenue6.6.3 Water Corporation Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.4.4 Water Corporation Products Offered6.7.5 Water Corporation Recent Development6.8 Sigma-Aldrich6.8.1 Sigma-Aldrich Biochemical Reagent Production Sites and Area Served6.8.2 Sigma-Aldrich Description, Business Overview and Total Revenue6.8.3 Sigma-Aldrich Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.8.4 Sigma-Aldrich Products Offered6.8.5 Sigma-Aldrich Recent Development6.9 Agilent Technologies Inc.6.9.1 Agilent Technologies Inc. Biochemical Reagent Production Sites and Area Served6.9.2 Agilent Technologies Inc. Description, Business Overview and Total Revenue6.9.3 Agilent Technologies Inc. Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.9.4 Agilent Technologies Inc. Products Offered6.9.5 Agilent Technologies Inc. Recent Development6.10 Betcon Dickinson6.10.1 Betcon Dickinson Biochemical Reagent Production Sites and Area Served6.10.2 Betcon Dickinson Description, Business Overview and Total Revenue6.10.3 Betcon Dickinson Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.10.4 Betcon Dickinson Products Offered6.10.5 Betcon Dickinson Recent Development6.11 Roche6.11.1 Roche Biochemical Reagent Production Sites and Area Served6.11.2 Roche Biochemical Reagent Description, Business Overview and Total Revenue6.11.3 Roche Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.11.4 Roche Products Offered6.11.5 Roche Recent Development6.12 AB Analitica6.12.1 AB Analitica Biochemical Reagent Production Sites and Area Served6.12.2 AB Analitica Biochemical Reagent Description, Business Overview and Total Revenue6.12.3 AB Analitica Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.12.4 AB Analitica Products Offered6.12.5 AB Analitica Recent Development6.13 Gesan Production6.13.1 Gesan Production Biochemical Reagent Production Sites and Area Served6.13.2 Gesan Production Biochemical Reagent Description, Business Overview and Total Revenue6.13.3 Gesan Production Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.13.4 Gesan Production Products Offered6.13.5 Gesan Production Recent Development6.14 Medicalsystem Biotechnology Co., Ltd.6.14.1 Medicalsystem Biotechnology Co., Ltd. Biochemical Reagent Production Sites and Area Served6.14.2 Medicalsystem Biotechnology Co., Ltd. Biochemical Reagent Description, Business Overview and Total Revenue6.14.3 Medicalsystem Biotechnology Co., Ltd. Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.14.4 Medicalsystem Biotechnology Co., Ltd. Products Offered6.14.5 Medicalsystem Biotechnology Co., Ltd. Recent Development6.15 Promega6.15.1 Promega Biochemical Reagent Production Sites and Area Served6.15.2 Promega Biochemical Reagent Description, Business Overview and Total Revenue6.15.3 Promega Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.15.4 Promega Products Offered6.15.5 Promega Recent Development6.16 PZ CorAugust6.16.1 PZ CorAugust Biochemical Reagent Production Sites and Area Served6.16.2 PZ CorAugust Biochemical Reagent Description, Business Overview and Total Revenue6.16.3 PZ CorAugust Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.16.4 PZ CorAugust Products Offered6.16.5 PZ CorAugust Recent Development6.17 SENTINEL CH.6.17.1 SENTINEL CH. Biochemical Reagent Production Sites and Area Served6.17.2 SENTINEL CH. Biochemical Reagent Description, Business Overview and Total Revenue6.17.3 SENTINEL CH. Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.17.4 SENTINEL CH. Products Offered6.17.5 SENTINEL CH. Recent Development6.18 Teco Diagnostics6.18.1 Teco Diagnostics Biochemical Reagent Production Sites and Area Served6.18.2 Teco Diagnostics Biochemical Reagent Description, Business Overview and Total Revenue6.18.3 Teco Diagnostics Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.18.4 Teco Diagnostics Products Offered6.18.5 Teco Diagnostics Recent Development6.19 Dickinson & Company6.19.1 Dickinson & Company Biochemical Reagent Production Sites and Area Served6.19.2 Dickinson & Company Biochemical Reagent Description, Business Overview and Total Revenue6.19.3 Dickinson & Company Biochemical Reagent Sales, Revenue and Gross Margin (2015-2020)6.19.4 Dickinson & Company Products Offered6.19.5 Dickinson & Company Recent Development 7 Biochemical Reagent Manufacturing Cost Analysis7.1 Biochemical Reagent Key Raw Materials Analysis7.1.1 Key Raw Materials7.1.2 Key Raw Materials Price Trend7.1.3 Key Suppliers of Raw Materials7.2 Proportion of Manufacturing Cost Structure7.3 Manufacturing Process Analysis of Biochemical Reagent7.4 Biochemical Reagent Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers8.1 Marketing Channel8.2 Biochemical Reagent Distributors List8.3 Biochemical Reagent Customers 9 Market Dynamics9.1 Market Trends9.2 Opportunities and Drivers9.3 Challenges9.4 Porters Five Forces Analysis 10 Global Market Forecast10.1 Global Biochemical Reagent Market Estimates and Projections by Type10.1.1 Global Forecasted Sales of Biochemical Reagent by Type (2021-2026)10.1.2 Global Forecasted Revenue of Biochemical Reagent by Type (2021-2026)10.2 Biochemical Reagent Market Estimates and Projections by Application10.2.1 Global Forecasted Sales of Biochemical Reagent by Application (2021-2026)10.2.2 Global Forecasted Revenue of Biochemical Reagent by Application (2021-2026)10.3 Biochemical Reagent Market Estimates and Projections by Region10.3.1 Global Forecasted Sales of Biochemical Reagent by Region (2021-2026)10.3.2 Global Forecasted Revenue of Biochemical Reagent by Region (2021-2026)10.4 North America Biochemical Reagent Estimates and Projections (2021-2026)10.5 Europe Biochemical Reagent Estimates and Projections (2021-2026)10.6 Asia Pacific Biochemical Reagent Estimates and Projections (2021-2026)10.7 Latin America Biochemical Reagent Estimates and Projections (2021-2026)10.8 Middle East and Africa Biochemical Reagent Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source12.1 Methodology/Research Approach12.1.1 Research Programs/Design12.1.2 Market Size Estimation12.1.3 Market Breakdown and Data Triangulation12.2 Data Source12.2.1 Secondary Sources12.2.2 Primary Sources12.3 Author List12.4 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Read more here:
Biochemical Reagent Market is Expected to Witness Significant Growth-Says QYResearch | Thermo Fisher Scientific, Beckman Coulter - Weekly Wall

Jennifer Surtees is a biochemist at UB. For more than two decades, her research has focused on genome stability and how mutations threaten that stability and sometimes lead to cancer.

But when the COVID-19 pandemic caused the temporary shutdown of UB research laboratories last March, Surtees, like many of her colleagues, couldnt help but consider how her expertise might be applied to the novel coronavirus.

When the pandemic started, there was a huge surge of interest research-wise into the pandemic and trying to understand how the virus moved around, says Surtees, associate professor of biochemistry in the Jacobs School of Medicine and Biomedical Sciences at UB and director of UBs Genome, Environment and Microbiome Community of Excellence.

I had watched the early genome sequencing coming out of Seattle and California, and I thought we could totally do this here, she says.

Surtees contacted UBs Office of the Vice President for Research and Economic Development to ask if anyone at UB was doing genome sequencing of the SARS-COV2 virus isolated from Western New York patients. No one was.

So she contacted Teresa Quattrin, senior associate dean for research integration in the Jacobs School and Special Populations Core director in the Clinical and Translational Science Institute; Gale Burstein, Erie County health commissioner and a Jacobs School faculty member; and Carleen Pope, administrative coordinator of the Erie County Public Health Laboratory. All were enthusiastic about Surtees idea.

Its an interesting epidemiological question to get a sense of where the virus is circulating in our community, Surtees says. Are there versions that are more pathogenic or infectious? I wanted to see what we could learn about the accumulation of mutations in Western New York patients.

Surtees explains that rapid genomic sequencing could be used alongside contact tracing to understand transmission of the virus through communities, with the goal of understanding how mutations affect clinical outcomes.

The goal with this project is to get a sense of the evolution of the virus, and where it came from, to find out its genomic epidemiology, to try and understand the biology of this virus, she says.

To do that, she worked with researchers in the sequencing core headed by Norma J. Nowak, executive director of UBs New York State Center of Excellence in Bioinformatics and Life Sciences. Donald Yergeau, associate director of genomic technologies in the Genomics and Bioinformatics Core, established a wet lab pipeline to convert the viral (SARS-CoV-2) RNA genomes derived from patients to DNA through reverse-transcription. The DNA version of the entire genome for each sample was amplified in small fragments and subjected to next-generation sequencing.

Jonathan Bard, a senior bioinformatician, then established a bioinformatics pipeline to compare the sequenced Erie County genomes with the reference genome, the original virus that circulated in Wuhan, China, to identify any changes or mutations in the genome.These genome sequences were uploaded into the nextstrain.org platform to assess phylogeny, a kind of family tree for the viral strains in Erie County, Surtees explains. This predicts the path the virus may have taken to get from Wuhan to Buffalo.

By July, Surtees had received Institutional Review Board approval to study the first batch of 50 deidentified (anonymous) samples isolated from nasal swabs from Western New York patients with COVID-19. They retrieved reliable sequence data from 32 of the samples. Now that that pipeline is in place, Surtees and her team can crank through new samples much more quickly.

Over time, mutations accumulate; thats just life, Surtees says, It happens in all organisms that replicate their genomes. Studying mutations provides us with an evolutionary path. It tells us which genomes are more closely related, the same way we can tell how closely people are related by looking at changes in their DNA sequences. The more mutations that two genomes have in common, the more closely related they are. Genomic sequencing also allows us to see how quickly the virus is mutating.

The question is to find out how mutations may affect infectivity of the virus, to find out which, if any, mutations are functional and which are just being carried along, she continues.

In the first batch of samples from patients who were sick with COVID-19 in early April, the majority, approximately two thirds, of virus samples from Western New Yorkers seemed to be of European origin, primarily Italy, France and Spain. The remaining third appears to have come through China and Singapore.

Surtees says the data from the samples will prove more valuable if it is possible to gather more information, such as gender, age and travel history, from the patients from whom the samples were taken. Since the samples were deidentified, that will require permission from Erie County and from each individual patient, as well as approval by UBs IRB.

Recently, the UB researchers received another 200 samples from the Erie County Public Health Laboratory, which they are running through the pipeline as well.

Surtees has received a small grant from the SUNY Research Foundation to pursue this work, as well as some funding from UBs Genome, Environment and Microbiome Community of Excellence.

She also has begun collaborating on the COVID-19 research with Amy Jacobs, a virologist and research associate professor in the Department of Microbiology and Immunology in the Jacobs School, and with Omer Gokcumen, an evolutionary biologist and associate professor of biological sciences in the College of Arts and Sciences.

They have applied for external funding from the National Institute of Allergy and Infectious Disease of the National Institutes of Health.

Read the original:
Predicting the path of COVID-19 from Wuhan to Buffalo - University at Buffalo Reporter

Global Biochemical Sensor market Size study report with COVID-19 effect is considered to be an extremely knowledgeable and in-depth evaluation of the present industrial conditions along with the overall size of the Biochemical Sensor industry, estimated from 2020 to 2026. The research report also provides a detailed overview of leading industry initiatives, potential market share of Biochemical Sensor , and business-oriented planning, etc. The study discusses favorable factors related to current industrial conditions, levels of growth of the Biochemical Sensor market, demands, differentiable business-oriented approaches used by the manufacturers of the Biochemical Sensor industry in brief about distinct tactics and futuristic prospects.

The latest report on Biochemical Sensor market is drafted with an aim to provide competitive edge to organizations operating in this business space by thorough analysis of global trends. The document enables companies to understand prevailing market dynamics as well as growth prospects so as to form important expansion strategies.

The study highlights the main drivers and opportunities which will influence the remuneration of the industry over the forecast period. It further enlists the challenges and threats hampering the market growth and provides recommendations to overcome these hurdles.

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/304428

Biochemical Sensor market report offers a comparative analysis of the past and present business outlook to infer growth rate of the industry over the analysis timeframe. Moreover, an in-depth scrutiny of impact of COVID-19 on the market landscape is entailed in the report, alongside the strategies to guide the industry partakers in converting this global distress into profitability.

Key pointers from table of content:

Product scope

Application spectrum

Regional terrain

Competitive hierarchy:

All in all, the report examines Biochemical Sensor market qualitatively and quantitively considering different segmentations and focusing on other important aspects such as supply chain and sales channel to infer overall industry augmentation for forecast duration.

Questions Answered by the Report:

Which are the dominant players of the global Biochemical Sensor market?

What will be the size of the global Biochemical Sensor market in the coming years?

Which segment will lead the global Biochemical Sensor market?

How will the market development trends change in the next five years?

What is the nature of the competitive landscape of the global Biochemical Sensor market?

What are the go-to strategies adopted in the global Biochemical Sensor market?

Table of Contents:

1 Study Coverage

1.1 Biochemical Sensor Product Introduction

1.2 Key Market Segments in This Study

1.3 Key Manufacturers Covered: Ranking of Global Top Biochemical Sensor Manufacturers by Revenue in 2019

1.4 Market by Type

1.4.1 Global Biochemical Sensor Market Size Growth Rate by Type

1.5 Market by Application

1.5.1 Global Biochemical Sensor Market Size Growth Rate by Application

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Biochemical Sensor Market Size, Estimates and Forecasts

2.1.1 Global Biochemical Sensor Revenue Estimates and Forecasts 2015-2026

2.1.2 Global Biochemical Sensor Production Capacity Estimates and Forecasts 2015-2026

2.1.3 Global Biochemical Sensor Production Estimates and Forecasts 2015-2026

2.2 Global Biochemical Sensor , Market Size by Producing Regions: 2015 VS 2020 VS 2026

2.3 Analysis of Competitive Landscape

2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

2.3.2 Global Biochemical Sensor Market Share by Company Type

2.3.3 Global Biochemical Sensor Manufacturers Geographical Distribution

2.4 Key Trends for Biochemical Sensor Markets & Products

2.5 Primary Interviews with Key Biochemical Sensor Players (Opinion Leaders)

3 Market Size by Manufacturers

3.1 Global Top Biochemical Sensor Manufacturers by Production Capacity

3.1.1 Global Top Biochemical Sensor Manufacturers by Production Capacity (2015-2020)

3.1.2 Global Top Biochemical Sensor Manufacturers by Production (2015-2020)

3.1.3 Global Top Biochemical Sensor Manufacturers Market Share by Production

3.2 Global Top Biochemical Sensor Manufacturers by Revenue

3.2.1 Global Top Biochemical Sensor Manufacturers by Revenue (2015-2020)

3.2.2 Global Top Biochemical Sensor Manufacturers Market Share by Revenue (2015-2020)

3.2.3 Global Top 10 and Top 5 Companies by Biochemical Sensor Revenue in 2019

3.3 Global Biochemical Sensor Price by Manufacturers

3.4 Mergers & Acquisitions, Expansion Plans

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/304428

Read the rest here:
Biochemical Sensor Market to Exhibit Impressive Growth of CAGR during the perio - News by aeresearch

When you think about the phrase online learning, what pops into your head? Snore-inducing webinars with no opportunity to interact or even submit questions? A recorded lecture that keeps disconnecting midsentence (buffering buffering )? A narrated PowerPoint in which the slides are filled with far too much text in creative fonts against eye-straining background colors and a voiceover whose pace is way too fast or slow? A course that prevents you from proceeding past any single page until the snail-like timer runs down and then baffles you with a poorly written reading-comprehension question?

Many of us have experienced such frustratingly poor examples of remote courses. And most liberal-arts colleges, including Southwestern, have long resisted the sway of distance learning because they pride themselves on close bonds between professors and undergraduates, the residential experience, and immersive education. So when the COVID-19 pandemic forced universities large and small, public and private to transition rapidly to remote teaching and learning this past March, many faculty and students understandably balked.

Still, distance education, whether you love it or hate it, has existed for decades, and online learning has made significant strides forward since the Internet became public in 1991and even greater leaps in just the past 10 years. Well beyond stilted webinars and passively viewed presentations, the field has grown to encompass game-based courses, multimedia archives, interactive storytelling and branching scenarios (think Choose Your Own Adventure), virtual labs and studios, and robust real-time and asynchronous chat forums. For many populations, distance learning is their education format of choice: its often self-paced, it enables study from any location that has Internet access, it better accommodates the schedules of adult learners with families and/or jobs, it can broaden students technological skills, it prepares students for remote jobs (a growing trend even before COVID-19), and it can virtually connect students and faculty from across the globe.

Online learning offers an additional benefit: it opens up an experimental space for innovating their pedagogy.

And for many teachers and professors, including faculty at SU, online learning offers an additional benefit: it opens up an experimental space for innovating their pedagogy.

Theres a negative perception of online learning for multiple reasons: in the spring, we made the switch really quickly, and not everyone did a good job. [Students and faculty] had negative experiences at other universities and at larger schools where they dont connect with students as well, says Professor and Garey Endowed Chair in Chemistry Maha Zewail-Foote. Hybrid and online courses this fall at SU, however, will rise above expectations, she believes, in large part because of the close mentoring relationships faculty and students enjoy. At Southwestern, the in-person experience is who we are. But we can take what were good at and are able to transition that to the remote environment . I like the creativity. Im excited because its an opportunity!

Most Southwestern professors expressed deep skepticism of online learning back in March and April, but the mood for many has changed to cautious optimism six months later thanks to a summer filled with conversations and training workshops to improve their remote-teaching practices. By collaborating with the staff at the Center for Teaching, Learning, and Scholarship and working independently, faculty have worked diligently to improve on the remote courses they were forced to create in only two weeks time last spring: they have revised their syllabi to prepare for all teaching formats, enhanced their online course development, and become more comfortable with learning technologies so that students will have even greater access to their instructors this fall, whether they are learning on campus or remotely. Their experiences mirror that of writing students who learn more about the conventions of different genres and the field of literature more broadly by being asked to re-present the same topic or theme in different forms, such as a short story, a poem, and a play. Similarly, professors are reassessing their approaches to teaching and enhancing student learning overall by translating their courses into the new context of online education.

But Zewail-Foote is one of the faculty members who approached even her spring classes with the enthusiastic spirit of taking on a challenge and adapting to new circumstances. While teaching Advanced Biochemistry Lab and The Biochemistry of Nucleic Acids last semester, she made it her goal to develop online assignments that still achieved the original learning objectives of her classes. She also used digital resourcessuch as whiteboards, videos, video conferencing, real-time collaboration tools, and chat roomsto continue cultivating the sense of community that characterizes her in-person classes. Although mediated by screens rather than interacting face-to-face, she remarks, I was still able to connect with them, and it was still fun, she remarks. Her students, she says proudly, remained engaged, active, and motivated.

In July, the chemistry professor published a paper describing her positive experiences, Pivoting an Upper-Level, Project-Based Biochemistry Laboratory Class to Online Learning during COVID-19: Enhancing Research Skills and Using Community Outreach to Engage Undergraduate Students. The publication appears in a recent issue of Journal of Chemical Education that focuses on online teaching.

Zewail-Foote, who is also a visiting scholar at the Dell Pediatric Research Institute at the University of Texas at Austin, reveals that the online environment can afford certain opportunities that she could not take advantage of in her brick-and-mortar classrooms, such as introducing her students to instruments or procedures that are not available on campus. There are limitations of the hands-on activities she would normally facilitate in a lab class, of course. But regardless of the venue, her focus remains on students learning how to think like scientists. I cant do in-person experiments, but I can help students learn about science and think about how to solve problems, report and describe the data, and present their findings, she says. And there are multiple ways to solve a problem, so they still get to learn through inquiry, creativity, and curiosity.

The online environment affords certain opportunities that [professors] could not take advantage of in [their] brick-and-mortar classrooms.

Zewail-Footes article also includes her insights on developing a community outreach project, Making a Difference, for the class. In the midst of the pandemic, the chemistry professor and her students switched gears by asking themselves, How can we help people? They then channeled what they had already learned into serving their local neighborhoods. The students could work alone or in groups and choose small or large projects; the primary requirement was that it had to relate to science. Because they were designing their projects remotely, Zewail-Foote notes, Everyone could do what they wanted to do. They could pursue their individual passions. And because they were studying remotely, the students could extend their volunteer engagement to the various communities they were living inacross Texas and across the nation.

While reflecting on her experiences with remote teaching and conversations with colleagues, Zewail-Foote praises her fellow STEM faculty especially, crediting their ability to move their classes online because of the interactive approach they take to teaching even during a traditional semester. In K12 and higher-ed circles, this is known as a flipped classroom, in which students explore introductory material on their own and class time is reserved for working through more challenging applications and problem-solving. Long lectures with professor-led demonstrations and limited discussion are no longer the norm. Chemistry and biology class is not the same as 20 years ago! she laughs.

Zewail-Foote herself has been using this more inquiry-based and active-learning approach for years: she creates short videos, five to eight minutes long apiece, for her students to view at home. She also assigns introductory readings and worksheets with questions. Then, in class, instead of monologuing while her students sit, listen, and take notes, Zewail-Footes students ask questions, work through problems together, and synthesize ideas so that they are prepared to engage in more challenging homework the next evening. Its a teaching model that trains students to be scientists by doing science the way that STEM scholars research and experimentand one that earned her recognition in a Chronicle of Higher Education article in 2013.

Zewail-Foote asserts that the implementation of flipped classrooms made the switch to hybrid or all-online learning more seamless. People picture webinars, but a remote class at Southwestern is good, Zewail-Foote asserts. The lab part is challenging because they dont do hands-on work, but SU does it well. The students preview [what theyre learning], they practice it, and they master it. The Southwestern Experience is engaging, and even when the students are online, theyre going to be creative, theyre going to be inquisitive, and theyre going to reach out to the community. None of that is taken away.

The Southwestern Experience is engaging, and even when the students are online, theyre going to be creative, theyre going to be inquisitive, and theyre going to reach out to the community.

That dedication to curiosity, inquiry, and public service will remain crucial as COVID-19 continues to make its rounds throughout the country and across the world. Cursory glances at social media, for example, underscore how learning science and scientific literacy (as well as information and media literacy) is more important than ever, not just as an intellectual passion among researchers but also for the health and safety of the public. Tackling the coronavirus is going to depend on science, and so we need sciencewe need to learn science, Zewail-Foote observes. Ive been teaching a long time, and I finished school many years ago, but does that mean Im done learning? No! Science is changing. The world is changing. While teaching last spring, she was able to model the very outcomes of a scientific education in the midst of a global health crisis, such as knowing how to evaluate the validity and quality of sources, read and understand scientific articles, develop questions, and find the right people or resources to consult. Those skills are learned and emulated by her undergraduates. Students dont always realize that Im trying to teach them how to learn so that they can learn forever, but that is what they are going to learn here, she says, and we can merge that Southwestern Experience with remote learning in a positive way.

For Zewail-Foote, its important to remind ourselves that not all educational experiences are held equal: the student (and faculty) experience can differ wildly between K12 and higher education, between community colleges and four-year universities, between large state schools and private colleges, and even within individual institutions. Indeed, as those of us who have studied and taught in a variety of educational settings can say from experience, the quality of instruction and learning varies regardless of whether it takes place in a classroom, through distance learning, or in a hybrid format. Any classs success instead depends on such factors as careful course design, the instructors depth and breadth of knowledge, their ability to engage students, the students level of motivation and participation, the assignment of meaningful activities, and mutual respect among students and between students and their teacher.

Luckily, students can rely on their SU professors to fulfill their commitment to providing meaningful and memorable educational experiences regardless of whether classes take place in person, online, or both. Southwestern is now in its second week of offering mostly in-person courses, but more than 30% of courses are currently remote only, with many students having specifically requested the online option. Fortunately, Southwestern faculty have prepared for all formats. And, as Zewail-Footes publication and experience illustrate, those classes, even if online, will continue to be as dynamic, engaging, and interactive as the in-person courses the university is known for.

View original post here:
Keeping an Open Mind: The Opportunities of Remote Learning - Southern Newsroom

The No. 1-ranked distance runner in the country happens to be the star runner from Rawlins. Its senior Sydney Thorvaldson.

She sits atop the list of the MileSplit 50.

Last Saturday at the Heritage Distance Classic in Colorado, Thorvaldson produced the fastest 5K run of the year with a time of 16:19. Its a new course record and a new personal record. The event was held on the Liberty Bell Invitational course in Littleton, CO. That event was canceled earlier this year due to the virus.

Thorvaldson became just the eighth female runner all-time in cross country to record a time under 16:30 in a 5K. She accomplished the feat on a course thats just over 5,300 feet in elevation.

The Rawlins senior is already the most-decorated runner in Wyoming state history. Thorvaldson is a 15-time state champion and has been honored with the most Gatorade awards in the state with five. She also owns nine state records.

Add another accomplishment to the list with her time under 16:30.

In case you missed it earlier this summer, WyoPreps David Settle went to Rawlins to visit with Thorvaldson in-person to gain more of a perspective on the senior. She spoke on a variety of topics, including running, her top college choices shes looking at, and even what shes interested in away from running. You can watch that video below. It also includes her coachs perspective, from Rawlins coach Nancy Steinberg.

Rawlins will host the Rawlins Invitational on Friday, Sept. 18 at Sinclair.

Source: MileSplit.com

Go here to see the original:
Sydney Thorvaldson Ranks No. 1 in the Nation for Cross Country - WyoPreps

Yeah, that was good. Yeah, Id do that again. When you click through it click, click, click, click I find it quite exciting. Sorry to be immodest about it.

Jeremy Sinclair is talking Campaign through a slideshow of 25 of his favourite ads that he and his business partners, Bill Muirhead and David Kershaw, have picked from the last half-century of working first for Saatchi & Saatchi and then M&C Saatchi.

It is an awesome display: Pregnant man, which encouraged family planning; Labour isnt working, which helped Margaret Thatcher get elected; The fat lady sings for Silk Cut, which marked the end of cigarette advertising. Then theres New Labour, new danger with Tony Blairs demon eyes. Another Conservative election poster of Ed Miliband in Alex Salmonds pocket. And, to make it topical, one of the latest campaigns Looks like you need Iceland to promote tourism by getting people to scream into the internet.

There is a current running through those ads of high impact, in your face, simple, hopefully world-changing or market-changing, Kershaw says, sitting alongside Muirhead and Sinclair on a Zoom call. Theres no doubt, when you see those ads, you see Saatchi.

Sinclair, Muirhead and Kershaw should know. In the case of Sinclair, the creative, he has been there since before day one, 50 years ago, when Charles Saatchi and his brother Maurice announced the launch of Saatchi & Saatchi in Campaign on 11 September 1970.

Muirhead and Kershaw, the two account men, joined in 1972 and 1982 the glory days when Saatchi & Saatchi was known as the biggest and the best in the world, before the brothers over-extended themselves and lost control. The five of them went on to set up a breakaway agency, M&C Saatchi, in 1995 and became equal partners.

Charles was barely involved as he focused on his art collection but Maurice stayed, albeit in an increasingly semi-detached way, until December 2019. Thats when he sensationally quit, along with all of the non-executive directors, in a row over 11.6m of accounting irregularities and adjustments, and its stock market value crashed 80% to about 70m.

And now there are just three: Sinclair, 73, earnest and passionate; Muirhead, 74, debonair with Australian charm; and Kershaw, 66, a jolly, clubbable Arsenal fan.

The trio remain loyal to the original Saatchi ethos what Kershaw describes as an outrageous desire to change the world, to do things dramatically with no pussy-footing but the last year has been tough.

The accounting problems first came to light in August 2019 and, more than 12 months later, the 2018 accounts had still not been published, which delayed the release of the 2019 numbers too.

Its been the worst year weve had by a country mile, Sinclair admits, referring to the endless checks by external auditors and a Financial Conduct Authority investigation.

It doesnt stop, he says. I go home and Im still dealing with it. It is the relentless nature of it that has been the most knackering.

Sinclair, the chairman, Kershaw, the chief executive, and Muirhead, an executive director, know their time in charge is drawing to an end and are thinking about their legacy.

There was speculation that they might resign last December but they didnt want to run away and felt a sense of responsibility. Weve got to get this bit right and then move on, Muirhead says.

Vin Murria, a serial tech entrepreneur and investor, bought a 13.25% stake in May in a surprise move that signalled M&C Saatchis future could be up for grabs.

Sinclair, Muirhead and Kershaw own only 12% between them, and other predators are said to be watching.

Thats why the twin anniversaries the 25th birthday of M&C Saatchi and the 50th of Saatchi & Saatchi, which is now owned by Publicis Groupe carry additional significance for Sinclair, Muirhead and Kershaw because there is a sense of finality.

Saatchi is still the most famous name in global advertising and, as the trio reveal in this interview, they still hold out hope that the two rival agencies might be reunited one day.

By contrast, Charles and Maurice are in no mood to mark the anniversaries unlike 10 years ago, when M&C Saatchi and Saatchi & Saatchi threw a huge, joint bash at Charles Saatchi Gallery, attended by Baroness Thatcher and other big names from politics and the media.

When Campaign approached Charles about this article and sent him a copy of the 1970 launch interview he gave to this magazine he replied by email: Sorry to say that I have no wish to participate. Apologies for being a dud.

Maurice, who was a business executive at Haymarket, the owner of Campaign, before starting up Saatchi & Saatchi with his older brother, also declined to talk in keeping with his policy of saying nothing since quitting M&C Saatchi last year.

This, then, is the story of the Saatchis three most loyal lieutenants. A trio who are arguably more dedicated than even the brothers to sustaining the Saatchi advertising brand.

Charles ambition and vision for Saatchi & Saatchi were evident in that pulsating Campaign interview from 50 years ago that we republish as part of our coverage. He was 27 and already wise beyond his years because he had started in advertising in his teens, Sinclair recalls.

Charles had already run a consultancy, Cramer Saatchi, which he set up in 1967, and was on a high as the team, which included Sinclair, had just produced the Pregnant man, which had picked up a clutch of industry awards.

Most advertising was either terrific or shit, according to Charles, who exuded energy, aggressive salesmanship and contempt for most existing agencies in the interview.

All our creative people have to act as if they were salesmen, he vowed. They have to imagine themselves in the clients position all the time. They have to see themselves with a warehouse full of product that has to be sold.

His comments resonate to this day as clients and agencies grapple with digital disruption and the need to grow again in a Covid world albeit Muirhead says the agency soon discovered that Charles couldnt leave all the selling to the creatives and it still needed account executives.

For Sinclair, Muirhead and Kershaw, that 1970 interview captures a lot of what made Saatchi such a powerful agency brand over the next 50 years.

We wanted to be the biggest and the best and you see this running right through the article, Sinclair recalls. When we started, all the big agencies were crap and all the great agencies were minute.

Part of the problem was the industry at the time was a club, he continues, as Muirhead and Kershaw let him do the talking. It had sherry at 11am, gin and tonic at 5pm, and it was all a lot of really nice people having a rather nice life. And then we came along.

Charles and Maurice, in particular, were outsiders from an Iraqi-Jewish family in north London and, whether they knew it or not, they had an outsiders marauding attitude, according to Sinclair.

If you can be Jewish Puritans, thats what we were. We didnt do any of the drinks, we didnt do any of the drugs, he explains, before Muirhead tries to correct him: Hang on, Jeremy! Sinclair chuckles: Sorry, this was before Bill joined.

A lot of the agency was staffed by young men in their early twenties and there was a freedom to do things that might not necessarily work and not be punished for it, Muirhead says. That I found really attractive when I first came. It brought a certain kind of person to the company the kind of people who would do things that other people thought werent possible. And that was very much there from the beginning. Hence the agencys mantra: Nothing is impossible.

The focus for Sinclair was the work. All we were there to do was to crash out great ads and the better the ads, the more we could get away with, he says. Charles was a great writer. We had a brief to tell people to wash their hands and he wrote, Wash your hands, you know where theyve been. It was in your face, it was making you think about your crotch without mentioning it, its what we did we were there to knock the socks off the world.

Charles had an innate ambition to make the Saatchi brand and work such as the Pregnant man famous, Sinclair says, while Maurice was a brilliant suit with clients, according to Kershaw.

With hindsight, it looks like Charles and Maurice wanted to build a mythology around the Saatchi name from the start but Sinclair insists: We never said we were doing that. We were building the brand.

Working for Thatcher on successive election-winning campaigns was crucial as it took a locally famous agency and made it globally famous, he says. It opened doors right across the planet because of what wed done. Indeed, four decades later, when Thatcher died in 2013, M&C Saatchi ran a tribute poster to the best client we ever had. Sinclair says: That was not fawning to anyone. We actually think she made the agency.

A lot of the Saatchi & Saatchi story between 1970 and 1995 has become part of advertising folklore and been told many times: the commercial expansion under Tim Bell, the managing director, who went on to found Bell Pottinger; the global M&A spree overseen by Martin Sorrell, the finance director, who quit to run WPP; the iconic headquarters at 80 Charlotte Street and the parties; the creation of Zenith, a pioneering media agency that aggregated the Saatchi agencies buying power; then the ill-fated bid for Midland Bank and taking on too much debt, followed by the boardroom coup against Maurice at the end of 1994 and Charles exit with him.

The accounts from that year give a picture of Saatchi & Saatchis scale: 11,000 staff and annual revenue of 775m but group operating margin was only 5.7% and it had net debt of 128m. The idea of being the biggest and the best turned into carry on growing until we got worse, Sinclair says, only half-joking.

For Maurice, in particular, who was ousted, his departure was a humiliation. As a result, there probably was an element of revenge for him and Charles when it came to starting up M&C Saatchi, according to Kershaw.

However, Sinclair, Muirhead and Kershaw chose to quit. They felt no bitterness because they had already been plotting to leave and launch their own shop (although their exit did trigger a spectacular legal battle with their old employer).

Saatchi & Saatchi continued, without the brothers and their lieutenants, and its history after 1995, when it became a subsidiary of Publicis Groupe, is important, but not the focus here.

The breakaway agency announced its arrival on the front page of Campaign in January 1995 but the story, Top Saatchi rebels join Maurices new agency, didnt fully reflect the power play behind the scenes.

The agency could easily have been called Sinclair, Muirhead and Kershaw with no mention of Saatchi because the trio came close to launching without the brothers involvement. How close? Very, Muirhead says.

However, the lure of the Saatchi brand and their loyalty to Maurice and Charles (below) were strong. Maurice phoned to ask them: What are you boys going to do? They told him about their start-up and he immediately consulted Charles, before calling them back five minutes later.

Maurice said: Ive spoken to Charles and we think its a brilliant idea that youre starting your company and wed like to join your company and we think you boys should have 5% each, Muirhead says, recalling how he and Kershaw were in Sinclairs office, listening in. And Jeremy said: Stop, stop, Maurice. Our days of serfdom are over. If you and Charles would like to join us, you can do as equal partners.

Maurice spoke to Charles again, they agreed to join, and M&C Saatchi was born. We gave away 40% of the equity for the name Saatchi, Sinclair says. We thought having spent 25 years making the name Saatchi famous, it was a door-opener for us. So thats how important we thought it was. We owned 100%. We went down to 60%, giving the two brothers 20% each, for the thrill of having M&C Saatchi in our title.

The new agencys proposition the new testament, Kershaw calls it was different. M&C Saatchi would focus on organic growth, rather than acquisitions, and eschew debt learning the lessons from what had happened between 1989 and 1994, Kershaw says. Obviously Martin had gone off to pursue that [M&A-driven] model brilliantly in his way [at WPP]. We thought wed do it differently.

Yet Sinclair insists that in some ways M&C Saatchi stuck to the core values from 1970: Why dont you look at it not as a new agency? Instead, they felt, it was a continuation of the old agency. We left the company because it was being taken off in a direction that we didnt recognise, authorise, believe in. In a way, we were just carrying on, according to Sinclair.

And it was exciting to start over. They wanted to see if lightning could strike twice, he says, because so many successful agency leaders dont have the partners, the glue or the luck second time round.

M&C Saatchi prospered. Some of Saatchi & Saatchis clients, notably British Airways and the Conservatives, joined the new agency, although the latters 1997 general election defeat signalled the times were changing.

The new shop wanted to be the most sought-after agency in the world and its slogan was Brutal simplicity of thought, although Sinclair concedes: We werent particularly out to be the best.

Charles left but Maurice remained a formidable handler of business, Kershaw says. He had an amazing relationship with Colin Marshall, who was chairman of BA, and with Mars. We wouldnt have got those businesses and we wouldnt have been able to make great work for them [without Maurice].

M&C Saatchi went on to float on the stock market in 2004 but avoided making big acquisitions. Instead it built an international network organically, backing agency entrepreneurs in local markets and giving them minority stakes in return that could be turned into shares.

The group also diversified by discipline as it moved into media, CRM, public relations, sports marketing and talent management. Savvy investments included backing Walker Media, which was eventually bought by Publicis Groupe, and M&C Saatchi Mobile, which is now M&C Saatchi Performance.

The basic model that says dont fuel it all by M&A and just raising capital all the time and buying stuff but actually find really talented people, whether that be in new verticals or geographies, and make them your partners and give them meaningful equity in it, I think that should last beyond us, Kershaw says.

And the Saatchi name, not just the offer of financial backing, has been a vital ingredient in attracting those agency entrepreneurs. In terms of developing the new model, it would have been a lot tougher without the Saatchi brand, Kershaw believes.

More agency talent will want a stake in their own businesses in future, according to Sinclair, who points to the record number of start-ups and people registering website domains in recent years across the UK economy. I think more and more people will refuse to be wage slaves, he predicts. Even people in jobs are starting things on the side.

M&C Saatchi has been a sweet set-up for Sinclair, Muirhead, Kershaw and Maurice Saatchi, who sat pretty in their shared office on the top floor of their Golden Square headquarters and were able to fend off questions about succession at least until the accounting problems.

Steadily rising revenue and profit growth were good for shareholders while the founders collected bonuses, dividends and even rent from the agency because they owned the freehold of the Golden Square building for a time.

One criticism of M&C Saatchis model is that it lacks genuine ambition. The group has 140 subsidiaries but it seems more like a collection of cottage businesses that are united by a brand and a network but have limited scale.

Sinclair concedes M&C Saatchi could have been bigger: But we still have grown quite nicely. Weve still got 2,200 or so people around the planet. Weve still got 140 companies.

The network might look complicated but the model itself is simple, he maintains: There is an area that does need finessing how do people get out of their local equity into the global equity? That model there is up for inspection at the moment and does need to be refined. (M&C Saatchis share price drop in the last year means the global equity is worth less.) That doesnt deny the fact that people work better, people look after their homes better, Mrs Thatcher said, if they own it, he says.

M&C Saatchis last accounts show annual revenues of 255m, making it a third of the size of Saatchi & Saatchi 25 years ago (and that excludes inflation). However, it had no debt, which was a blessing given what happened next, plus the Covid downturn.

M&C Saatchis board discovered irregularities at four UK subsidiaries after a new finance director joined the parent company in spring 2019. The company alerted shareholders in August, only to tell them in December that the situation was worse than feared.

Sinclair, Muirhead and Kershaw are wary of discussing the saga. Their faces stiffen and they say they are limited in what they can say for now because of the FCAs investigation.

You have to say we didnt have sufficient grip on the financial management of the company, a chastened Kershaw admits. At the end of the day, its our ultimate responsibility to make sure that the finances and controls of the company were correct.

They feel let down by people they trusted, Muirhead adds, but they have a determination to put it right, not to run away, not to try and avoid our responsibility. Sinclair agrees and, when asked to elaborate, refers to his entry in the Campaign A List earlier this year about his biggest screw-ups. Trusting accountants, he wrote.

Arguably the failings went beyond the finances. The groups many subsidiaries and back-office systems made it overly complex, even if it didnt lead to the accounting irregularities.

Kershaw points out there are only about 25 key companies within the 140 subsidiaries but concedes the complexity of that spiders web needs to be simplified, and M&C Saatchi will announce the results of a strategic review later in the autumn.

Then there was the issue of M&C Saatchis non-executive directors, Lord Dobbs, Sir Michael Peat and Lorna Tilbian. They made up less than half the board and two had links to the company that pre-dated them joining, which raised questions about independence. Kershaw doesnt disagree.

Still, once the irregularities emerged, the NEDs turned against Sinclair, Muirhead and Kershaw as did Maurice Saatchi, who resigned as an executive director in a one-line letter.

When asked, Sinclair, Muirhead and Kershaw say they have had no contact with Maurice since that day a brutal end to 49 years of working together.

I just wish him well, Sinclair says, referring to the grief that Maurice has suffered since being widowed.

None of the trio has had contact with Charles for years, but they find it easier to talk about him.

Charles will forever be on a pedestal in my mind, Sinclair says. He taught me everything I knew about advertising. I have tremendous affection for him and will do until I shuffle.

The bonds run deep between Sinclair, Muirhead and Kershaw and some of their long-serving colleagues such as Moray MacLennan (the most likely heir apparent) and Tim Duffy, who both joined from Saatchi & Saatchi. It is a family business, Sinclair says. We may not be blood family but we are family.

Sinclairs slideshow of work brings back many memories for the trio, who enthuse over past glories like the time a client dismissed the idea of putting an ad on the Berlin Wall when it fell in 1989. The agency ran the ad for itself and sent an executive to Germany with the banner that said: Saatchi & Saatchi first over the wall. Sinclair grins: We were the first agency to stick an advert on the wall you cant forget that. An advert for ourselves we keep doing that, we advertise ourselves.

They love talking about the work. Sinclair says: Its because were salesmen, really. Were showmen. He is still creating ads, including one to mark the joint 25th and 50th anniversaries. I get a kick out of it. When I wrote it the other day, I felt better afterwards. Is it a drug? I dont know but I love doing it. I love having a blank piece of paper theres nothing on it and then suddenly something appears on it. You think, Where did that come from? What is this? That to me is the pleasure of producing, out of an apparent nothing, something. I just think its a great thing to do. The more people that love it, the better it is.

Muirhead also remains in love with the craft, although he sees it more through the business lens of the account man: You can see afterwards what happened and it sells things. Its very satisfying being able to see after youve done something, products are sold or attitudes are changed.

Kershaw says: Its also a great act of transformation. People say: what is creativity? You give them the most boring explanation of what the selling message for the most boring product can be. And then, through an act of brilliance, you make that boring selling of something boring really interesting.

It will then change how people think or their attitudes to obesity or how they vote or what they do. There is a magic in that. You can go on for 10 minutes about how you feel and then someone puts it into a rhyming couplet. That act of creative transformation is one of the most exciting things in the world. Advertising just happens to be a great commercial manifestation of that creative act.

Their best work from the past 50 years has the same personality that you see in that Charles interview and is distinctive in its own way just like the gentle elegance of Abbott Mead Vickers or the loveliness of BMP morphing into Adam & Eve, Kershaw says.

The theory is nice but the reality is M&C Saatchis flagship UK ad agency has had a mixed record creatively the whole agency still seems to be defined by the work for Thatcher, one person who knows the founders says and a series of shortlived leadership teams. Last year, it lost NatWest, cut a tenth of jobs and merged with CRM shop Lida.

Sinclair remains resolutely upbeat, describing the current management team, Camilla Kemp and Ben Golik, as the best weve ever had.

The 50th and 25th anniversaries of the two rival agencies raise the question about whether M&C Saatchi and Saatchi & Saatchi might ever come back together as one. Muirhead admits: The great dream would have been to put the two companies back together and just have one name and to have it in its former glory combined.

Campaign understands there were discussions between M&C Saatchi and Publicis Groupe before the accounting irregularities about a possible combination. Both Sinclair and Maurice Saatchi talked to Maurice Levy, the long-serving chairman of the supervisory board of Publicis Groupe, at various points, including in around 2017.

I certainly had conversations with Maurice [Levy] a couple of years ago, Sinclair reveals. But it partly went nowhere because he, at the time, was very reluctant to let go of anything he had [for example, by spinning off Saatchi & Saatchi]. He was intent on copying what was then Martins model of just growing and growing and growing.

One of the things we put to him was, Why dont we mix Saatchi and M&C Saatchi and have it as an independent floated company?, where you Publicis have a substantial holding in it but so do the public, so that the [entrepreneurial] model can go on. But Levy could not be persuaded. In the end, that required him to let go of some of his Publicis billings. So, then he wouldnt do it, Sinclair says.

He adds wistfully but maybe the new man a reference to Arthur Sadoun, who replaced Levy as chief executive in 2017 might have another think about it. There could be an interesting model there somewhere, Sinclair says.

Kershaw sounds less hopeful. When the two sides started talking, Publicis Groupe had already begun to move to its Power of One model of bringing different agencies and disciplines together for clients such as Procter & Gamble under one roof. Sadly, the longer time we talked to them, the more difficult it was for them to let it [Saatchi & Saatchi] out [from the wider Publicis Groupe] because of the strategy.

Muirhead still holds out hope. It sort of hurt me that the original company is now a subsidiary of a French group, he says, and he is sad that some other big agencies named after their founders such as J Walter Thompson, which I never thought would disappear, have been axed recently. Who knows? Sometime in the future, maybe in my dreams, there would be a coming back together [of the two rival Saatchi brands] with the same spirit and new people.

Sinclair, Muirhead and Kershaws enduring love for the Saatchi brand is palpable. Weve moved 20 yards in 50 years, Sinclair says, noting the first office in 1970 was in Golden Square.

So how much have they become the Saatchi torchbearers as the brothers have lost interest? Saatchi always was a group of people, Sinclair says, referring to the old days at Saatchi & Saatchi. Maurice and Charles were the headline act. But the strength of the place was we managed to pull an extraordinary group of people together. It always was, in my view, a conglomerate.

Visit link:
M&C Saatchi co-founders: "From the outside it was theirs, but really it was ours" - CampaignLive

Researchers at the College of Education and Oregon Health and Science University are collaborating to address stress and burnout among special education teachers, especially as educators transition to online teaching.

The goal of Project Resilience: A Neurological and Psychosocial Collaborative to Prevent Occupational Burnout of K-12 Educators is to develop a better understanding of risk factors associated with burnout that can be identified prior to entering the field.

We are committed to finding approaches to address prevention, rather than crisis-oriented responses, said Chris Knowles, a research associate professor in the College of Education.

As a former special education teacher for students with emotional and behavioral challenges, Knowles has first-hand knowledge of the effects of working in such a demanding job.

Knowles, John Seeley, James Sinclair, Kate Bromley, Paulina Whitehat and Carolyn Griffith represent the University of Oregon in the project, while Alexander Stevens, David Lahna and Barry Oken represent OHSU.

Educators report that feeling high levels of stress can lead to leaving the field. Teachers with high stress and low coping abilities are associated with poorer student outcomes than teachers with low stress and better coping abilities.

Also, experiences of burnout are often associated with poor classroom environments and challenging student behavior. This is known as the burnout cascade, which occurs in three phases: emotional exhaustion, de-personalization and the feeling of a lack of accomplishment in ones work.

Given these findings, there is an urgent need to identify strategies to prevent or ameliorate teacher burnout in order to improve occupational well-being and reduce the epidemic of teacher attrition, Knowles said.

The team recently received a grant to support the development and design of a collaborative research plan. The team has collected exploratory data from special education teachers and graduate students.

Researchers are using a mixed-methods approach to analyze the data to learn about the phenomena of stress and burnout with attention to changes in education brought about by COVID-19. Though the data is still being analyzed, COVID-19 appears to have brought incredible changes in teaching demands.

Based on initial findings, it appears that the causes of stress have dramatically changed for teachers during the rapid transition to providing online instruction, Knowles said.

Research into teacher burnout has only been conducted within the past 10 years. Proposed strategies to address burnout, like mindfulness meditation and development of classroom management, have had relatively little effect on attrition.

The biological and neurological aspect of teacher burnout, however, has not been studied extensively. The research group proposes that investigating teacher burnout at both a biological/neurobiological and psychosocial level could offer a more comprehensive understanding of which prevention methods can be developed.

Our end goal is to use a variety of measures to identify risk and protective factors for burnout in special education teachers, Knowles said.

By identifying factors that could potentially cause burnout, special education licensure programs can identify education students who could benefit from additional support to manage stress prior to entering the job market.

Once additional research questions have been identified, the team will apply for more funding to conduct a pilot study, solidify a proof of concept and produce further publications that will be meaningful to education professionals.

Additional funding for this project will allow us to develop innovative and novel lines of research that capitalize on the strengths of the behavioral neuroscience program at OHSU and the Department of Special Education and Clinical Sciences in the College of Education at the UO, Knowles said.

By Meghan Mortensen, College of Education

View original post here:
UO, OHSU work to prevent special education teacher burnout - AroundtheO

ExploreVOICES: This is temporary. It is also painful, Dayton superintendent and board president say of 241 layoffs and furloughs

Shelly Sinclair taught us the following in our very first theatre class in 1992: professionals write it down, amateurs remember. In 2019, I either built, produced, directed, or acted in 44 productions.

One of those productions featured Rico Parker, an 2002 Colonel White graduate and member of Actors' Equity Association. The production was one of the most successful of the Columbus theater season, according to both its critical and community response.

I ask every stage manager who works with me to keep extra pens and tablet chargers in case the actors need help with their notes.

Michael Mangan conducted the orchestra where I played third cello at Stivers. His first lesson to us: I recently agreed to be the spokesperson for the Columbus Symphony Orchestra in a series of online videos to be aired weekly in the Columbus City elementary schools.

I could have achieved none of these things had I not received such a solid grounding at Stivers. My contemporaries and I received said grounding not just from the teachers listed above, but hundreds of others whove touched thousands of other students' lives, all through artistic education. We are intelligent, we are driven, we are expressive, and ultimately all most of us want to do is make a better world doing what we love to do.

Cutting those programs insults all of us. All the board has to do to correct the insult is reverse the decision and give Janelle the chance to bounce song and arrangement ideas off the teacher who inspired her to apply to Berklee in the first place.

Even if its via Zoom.

David Harewood is a freelance stagehand, director, and political/community organizer. He was born in Dayton, but now resides in Columbus.

Read this article:
VOICES: School layoffs irresponsible and senseless act that cheats Stivers students, artist says - Hamilton Journal News

LUMBERTON Two more men have been charged in relation to a 2015 home invasion during which a man was shot to death, according to the Robeson County Sheriffs Office.

Ismul Hines, 43, of Charlotte, and Kenneth McCoy, 26, of Laurinburg, both are charged with first-degree murder, four counts of armed robbery, assault with a deadly weapon, assault with a deadly weapon inflicting serious injury and seven counts of kidnapping, according to the Sheriffs Office. Hines also is charged with possession of a firearm by felon.

McCoy was placed in the custody of the Robeson County Detention without bond on the murder charge, according to the Sheriffs Office. He was given a $1.35 million secured bond on the remaining charges.

Hines was jailed at the Robeson County Detention without bond on the murder charge and was given a $1.4 million secured bond on the remaining charges.

On Sept. 28, 2015, at about 10:34 p.m., Sheriffs Office deputies responded to the 3300 block of Shaw Road in St. Pauls in reference to a home invasion. Upon the arrival, the deputies found Rodney Murphy, 51, of Maxton, deceased from a gunshot wound. During the home invasion two other males were shot and a female was assaulted.

Hines was living in Maxton at the time of Murphys death, according to the Sheriffs Office.

Quatrell D. Nicholson, 29, and Carson B. Brown, 31, both of Laurinburg, were arrested in 2016 in relation to Murphys death, according to the Sheriffs Office. Nicholson and Brown also are charged with first-degree murder, four counts of armed robbery, assault with a deadly weapon, assault with a deadly weapon inflicting serious injury and seven counts of kidnapping. Nicholson and Brown remain in custody.

The investigation continues.

Robeson County Districts Attorneys Office, Laurinburg Police Department and Charlotte Mecklenburg Police Department assisted with the investigation.

The arrests of Hines and McCoy are examples of continuous hard work and dedication to bring closure to the families of victims by Robeson County Sheriffs Office investigators, Sheriff Burnis Wilkins said. Investigators will continue to follow up on leads on unsolved murder cases and murders that have additional suspects who have not been charged.

Anyone with information about the case is asked to contact the Robeson County Sheriffs Office Homicide Division at 910-671-3100 or 910-671-3170.

Read more from the original source:
Two more men face charges in 2015 shooting death in St. Pauls - The Robesonian

Detective Comics #1027 brings an impressive roster of comic creators to celebrate 1,000 issues since the Dark Knight's debut on the title.

Over 80 years since Batman's debut in 1939's Detective Comics #27 by Bob Kane and Bill Finger, DC Comics has pulled out all the stops for Detective Comics #1027 to commemorate 1,000 issues since its flagship superhero's first appearance. With an all-star roster of comic book creators writing and illustrating a collection of short stories examining the Caped Crusader's extensive legacy, DC's latest oversized anniversary special explores the past, present and future of Batman, with most of the short stories serving as memorable quick takes on the iconic superhero.

With twelve stories in all, the special offers a chance to see longtime writers who had acclaimed, influential runs on the character in the past return for a new tale to weave starring the Dark Knight. Some examine Batman's impact through the eyes of the average, nondescript characters of Gotham City or through the prism of his most sinister villains. Some explore how Bruce Wayne still manages to show even the most experienced members of the Bat Family a thing or two out on the field. Some tease upcoming storylines that will have Batman play a prominent role. But in every single story in the anthology special, Batman's presence looms over the proceedings even in the cases when he himself isn't the respective story's protagonist.

RELATED:DC Debuts New Grant Morrison & Chris Burnham Hero in Detective Comics #1027 Preview

Even the stories featuring writers not as extensively associated with Batman do a good job, with Matt Fraction and Chip Zdarsky's tale revolving around Batman's relationship with his most hated nemesis as a particular standout while James Tynion IV and Riley Rossmo's short story focuses on Bruce's complicated relationship with death and the afterlife while refreshingly not coming off as dour and overly somber.There are multiple stories that use the anniversary as an opportunity to revisit Batman's Golden Age origins, with Grant Morrison and Chris Burnham's story perhaps being the most meta-textual nod and a strong callback to that original Kane/Finger story from 1939.

The issue really excels on its variety of artists, from Eduardo Risso's grounded, gritty style to Brad Walker, Andrew Hennessy and Nathan Fairbairn's full-bodied approach that perfectly sets the tone for the special right out the gate. David Marquez and Alejandro Sanchez get the chance to showcase the entire Bat Family in their story, providing a fun mystery while demonstrating the clear difference between the individual members through body language and action. And the most emotional story in the entire anthology issue has Tom King sync perfectly with Walter Simonson and Laura Martin while setting the stage for King's own upcoming Batman/Catwoman maxi-series as a clear reminder of the emotional core that resonated from his recently concluded run from the Batman ongoing series, with Simonson and Martin's visual delivered with especially heartbreaking aplomb.

View original post here:
REVIEW: Detective Comics #1027 Is an All-Star Celebration of the Dark Knight's History - CBR - Comic Book Resources